Global proteomic analysis distinguishes biologic differences in head and neck squamous carcinoma

Laboratory Investigation

Volumn 87, Issue 8, 2007, Pages 755-766

  Sudha, Rajagopalan ^a   Kawachi, Nicole ^a   Du, Peicheng ^a   Nieves, Edward ^a   Belbin, Thomas J ^a   Negassa, Abdissa ^a   Angeletti, Ruth Hogue ^a   Prystowsky, Michael B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarker; Cancer; Global proteomics; Squamous cell carcinoma

Indexed keywords

LIPOCORTIN 2; RNA; SYNTHETIC PEPTIDE; VIMENTIN;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; FOLLOW UP; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; ION EXCHANGE CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTAKE; PROTEOMICS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RNA EXTRACTION; RNA ISOLATION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; IONS; PEPTIDES; PHARYNGEAL NEOPLASMS; PROTEOME; REPRODUCIBILITY OF RESULTS; RNA; TANDEM MASS SPECTROMETRY; TONGUE NEOPLASMS;

EID: 34447578784     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700598     Document Type: Article

References (41)

1. Ferlay J, Bray F, Pissani P, et al. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5. 2001. IARC Press: Lyon. Ref Type: Serial (Book, Monograph).
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin 2007;57:43-66.
3. Barnes L, Verbin R, Guggenheimer J. Cancer of the oral cavity and oropharynx. In: Barnes L (ed). Surgical Pathology of the Head and Neck, 2nd edn. Marcel Dekker: New York, 2001, pp 370-438.
4. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446-1449.
5. Schwartz GJ, Mehta RH, Wenig BL, et al. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck 2000;22:34-41.
6. Takes RP, Baatenburg de Jong RJ, Schuuring E, et al. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1997;123:412-419.
7. Kyzas PA, Loizou KT, Ioannidis JP. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst 2005;97:1043-1055.
8. Lothaire P, de AE, Dequanter D, et al. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 2006;28:256-269.
9. McShane LM, Altman DG, Sauerbrei W. Identification of clinically useful cancer prognostic factors: what are we missing? J Natl Cancer Inst 2005;97:1023-1025.
10. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
11. Belbin TJ, Singh B, Barber I, et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 2002;62:1184-1190.
12. Head and Neck Cancer Group. Head and neck cancer: reduce and integrate for optimal outcome. Cytogenet Genome Res 2007 (in press).
13. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981;41:1657-1663.
14. Rangan SR. A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer 1972;29:117-121.
15. Luo Q, Siconolfi-Baez L, Annamaneni P, et al. Altered protein expression at early stage rat hepatic neoplasia. Am J Physiol Gastrointest Liver Physiol 2007;292:G1272-G1282.
16. Du P, Angeletti RH. Automatic deconvolution of isotope-resolved mass spectra using variable selection and quantized peptide mass distribution. Anal Chem 2006;78:3385-3392.
17. Du P, Sudha R, Prystowsky M, et al. Data reduction of isotope-resolved LC-MS spectra. Bioinformatics 2007 (in press).
18. Shrout P, Fleiss J. Intraclass correlation: uses in assessing rater reliability. Psychol Bull 1979;86:420-428.
19. Belbin TJ, Gaspar J, Haigentz M, et al. Indirect measurements of differential gene expression with cDNA microarrays. Biotechniques 2004;36:310-314.
20. Belbin TJ, Singh B, Smith RV, et al. Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol Head Neck Surg 2005;131:10-18.
21. Patel SG, Shah JP. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 2005;55:242-258.
22. Adrien LR, Schlecht NF, Kawachi N, et al. Classification of DNA methylation patterns in tumor cell genomes using a CpG island microarray. Cytogenet Genome Res 2006;114:16-23.
23. Madan R, Brandwein-Gensler M, Schlecht NF, et al. Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma. Head Neck 2006;28:1018-1027.
24. Yarbrough WG, Slebos RJ, Liebler D. Proteomics: clinical applications for head and neck squamous cell carcinoma. Head Neck 2006;28:549-558.
25. Diamandis EP. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps. Cancer Res 2006;66:5540-5541.
26. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005;97:1180-1184.
27. Zolg W. The proteomic search for diagnostic biomarkers: lost in translation? Mol Cell Proteomics 2006;5:1720-1726.
28. Seibert V, Ebert MP, Buschmann T. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery. Brief Funct Genomic Proteomic 2005;4:16-26.
29. Solassol J, Marin P, Maudelonde T, et al. Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers. Bull Cancer 2005;92:763-768.
30. Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 2004;3:367-378.
31. Henderson NA, Steele RJ. SELDI-TOF proteomic analysis and cancer detection. Surgeon 2005;3:383-390, 422.
32. Roesch EM, Nees M, Karsai S, et al. Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma. Eur J Cell Biol 2005;84:431-444.
33. Baker H, Patel V, Molinolo AA, et al. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol 2005;41:183-199.
34. Roesch-Ely M, Nees M, Karsai S, et al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 2007;26:54-64.
35. Fang R, Elias DA, Monroe ME, et al. Differential label-free quantitative proteomic analysis of Shewanella oneidensis cultured under aerobic and suboxic conditions by accurate mass and time tag approach. Mol Cell Proteomics 2006;5:714-725.
36. Nakamura T, Dohmae N, Takio K. Characterization of a digested protein complex with quantitative aspects: an approach based on accurate mass chromatographic analysis with Fourier transform-ion cyclotron resonance mass spectrometry. Proteomics 2004;4:2558-2566.
37. Qian WJ, Jacobs JM, Camp DG, et al. Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics 2005;5:572-584.
38. Ru QC, Zhu LA, Silberman J, et al. Label-free semiquantitative peptide feature profiling of human breast cancer and breast disease sera via two-dimensional liquid chromatography-mass spectrometry. Mol Cell Proteomics 2006;5:1095-1104.
39. Silva JC, Denny R, Dorschel C, et al. Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol Cell Proteomics 2006;5:589-607.
40. Gaspari M, Verhoeckx KC, Verheij ER, et al. Integration of two-dimensional LC-MS with multivariate statistics for comparative analysis of proteomic samples. Anal Chem 2006;78:2286-2296.
41. Stewart II, Zhao L, Le BT, et al. The reproducible acquisition of comparative liquid chromatography/tandem mass spectrometry data from complex biological samples. Rapid Commun Mass Spectrom 2004;18:1697-1710.